We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+17.88%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.59B
AUM Growth
-$182M
Cap. Flow
-$366M
Cap. Flow %
-23.08%
Top 10 Hldgs %
9.67%
Holding
757
New
81
Increased
81
Reduced
262
Closed
186

Top Buys

Rank Stock Value
1
LOGI icon
Logitech
LOGI
+$12.1M
2
PBF icon
PBF Energy
PBF
+$10.1M
3
FOXA icon
Fox Class A
FOXA
+$8.15M
4
WDC icon
Western Digital
WDC
+$7.88M
5
CAKE icon
Cheesecake Factory
CAKE
+$7.74M

Top Sells

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$18.8M
2
DUOL icon
Duolingo
DUOL
+$9.91M
3
RDDT icon
Reddit
RDDT
+$9.52M
4
OSCR icon
Oscar Health
OSCR
+$9.1M
5
LYFT icon
Lyft
LYFT
+$8.38M

Sector Composition

Rank Sector Weight
1 Technology 20.56%
2 Consumer Discretionary 15.19%
3 Healthcare 15.04%
4 Industrials 13%
5 Financials 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GH icon
176
Guardant Health
GH
$21.3B
$3.15M 0.2%
50,340
-52,034
-51% -$2.83M
ALHC icon
177
Alignment Healthcare
ALHC
$3.27B
$3.14M 0.2%
180,090
BSX icon
178
Boston Scientific
BSX
$68.4B
$3.14M 0.2%
32,116
ARWR icon
179
Arrowhead Research
ARWR
$12.1B
$3.13M 0.2%
90,819
-62,169
-41% -$1.37M
AVPT icon
180
AvePoint
AVPT
$2.75B
$3.1M 0.2%
206,635
-81,555
-28% -$1.37M
M icon
181
Macy's
M
$6.53B
$3.1M 0.2%
+172,800
New +$2.45M
WRBY icon
182
Warby Parker
WRBY
$3.25B
$3.09M 0.2%
112,193
-45
-0% -$1.14K
LILAK icon
183
Liberty Latin America Class C
LILAK
$1.63B
$3.07M 0.19%
399,506
STE icon
184
Steris
STE
$22.4B
$3.02M 0.19%
+12,196
New +$2.92M
CRL icon
185
Charles River Laboratories
CRL
$11.2B
$2.99M 0.19%
19,100
FLNC icon
186
Fluence Energy
FLNC
$1.87B
$2.97M 0.19%
275,067
-22,942
-8% -$192K
AER icon
187
AerCap
AER
$23.8B
$2.96M 0.19%
24,492
-24,800
-50% -$2.9M
ARCO icon
188
Arcos Dorados Holdings
ARCO
$1.73B
$2.96M 0.19%
438,466
-126,007
-22% -$894K
NOG icon
189
Northern Oil and Gas
NOG
$2.28B
$2.96M 0.19%
119,269
+82,714
+226% +$2.19M
SOFI icon
190
SoFi Technologies
SOFI
$21.1B
$2.94M 0.19%
111,337
-24,765
-18% -$588K
AUPH icon
191
Aurinia Pharmaceuticals
AUPH
$1.96B
$2.93M 0.19%
265,491
-63,210
-19% -$690K
BMRN icon
192
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.91M 0.18%
53,755
PNC icon
193
PNC Financial Services
PNC
$99.8B
$2.91M 0.18%
14,475
-3,619
-20% -$716K
ARQT icon
194
Arcutis Biotherapeutics
ARQT
$3.32B
$2.9M 0.18%
154,108
-36,875
-19% -$582K
ALGT icon
195
Allegiant Air
ALGT
$2.66B
$2.84M 0.18%
46,769
-25
-0.1% -$1.43K
GPGI
196
GPGI Inc
GPGI
$3.83B
$2.84M 0.18%
136,303
OPFI icon
197
OppFi
OPFI
$800M
$2.84M 0.18%
250,343
+215,060
+610% +$2.42M
MXL icon
198
MaxLinear
MXL
$6.25B
$2.8M 0.18%
174,226
TFII icon
199
TFI International
TFII
$11.1B
$2.8M 0.18%
31,740
NTRA icon
200
Natera
NTRA
$38B
$2.75M 0.17%
17,057
-12,700
-43% -$2.01M

Similar funds

PDT Partners's Q3 2025 Portfolio in Review

As of Q3 2025, PDT Partners held 757 positions worth $1.59B, down 10% from $1.77B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

PDT Partners withdrew a net $366M in Q3 2025, closing 186 positions and reducing 262 holdings. Its most notable exit was Duolingo, an estimated $9.91M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, PDT Partners opened a new position in PBF Energy worth $11.6M.

  • PDT Partners's largest Q3 2025 buy was PBF Energy: 384,666 shares worth $11.6M.
  • PDT Partners added most to Logitech in Q3 2025, an estimated $12.1M increase.
  • PDT Partners's biggest Q3 2025 reduction was Astera Labs, cutting an estimated $18.8M.
  • PDT Partners fully exited Duolingo in Q3 2025, selling an estimated $9.91M.
  • PDT Partners's ten largest holdings make up 9.7% of its $1.59B portfolio in Q3 2025.
  • PDT Partners opened 81 new positions and closed 186 in Q3 2025.
  • PDT Partners's portfolio value fell 10% quarter-over-quarter to $1.59B.

Based on PDT Partners's 13F filing for Q3 2025, filed 17 Nov 2025.